Current role
Hiroko Masamune
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Hiroko Masamune
The proxy statement of Viking Therapeutics, Inc. reports total compensation of $992,924 for Hiroko Masamune in fiscal 2018, including a base salary of $302,726.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Viking Therapeutics, Inc. (VKTX)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Viking Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Lian CEO, Board Member
- Greg Zante CFO
- Marianne Mancini COO
- Brian Lian, Ph.D. Board Member
- Charles A. Rowland Board Member
- J. Matthew Singleton Board Member
- Lawson Macartney, Ph.D. Board Member
- Matthew W. Foehr Board Member
- S. Kathryn Rouan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2018 | Viking Therapeutics, Inc. (VKTX) | Ph.D.^(^ ^)^ Former Chief Development Officer | $302,726 | $992,924 |
Recent activity
No call appearances or filed executive changes recorded yet.